These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39078096)

  • 1. Current laboratory testing practices for mismatch repair deficiency and microsatellite instability testing: A survey-based review of current laboratory practices.
    Austin AL; Broaddus RR; Souers RJ; Kane ME; Kolhe R; Miller DV; Moncur JT; Ramkissoon S; Tafe LJ; Trembath DG; Graham RP
    Am J Clin Pathol; 2024 Jul; ():. PubMed ID: 39078096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline.
    Vikas P; Messersmith H; Compton C; Sholl L; Broaddus RR; Davis A; Estevez-Diz M; Garje R; Konstantinopoulos PA; Leiser A; Mills AM; Norquist B; Overman MJ; Sohal D; Turkington RC; Johnson T
    J Clin Oncol; 2023 Apr; 41(10):1943-1948. PubMed ID: 36603179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of discrepant mismatch repair immunohistochemistry and microsatellite instability polymerase chain reaction test results for gynecologic cancers using next-generation sequencing.
    Smithgall MC; Remotti H; Hsiao SJ; Mansukhani M; Liu-Jarin X; Fernandes H
    Hum Pathol; 2022 Jan; 119():41-50. PubMed ID: 34666078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].
    Liu Y; Wang YX; Sun XJ; Ting X; Wu R; Liu XD; Liu CR
    Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):755-765. PubMed ID: 37849256
    [No Abstract]   [Full Text] [Related]  

  • 5. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.
    Luchini C; Bibeau F; Ligtenberg MJL; Singh N; Nottegar A; Bosse T; Miller R; Riaz N; Douillard JY; Andre F; Scarpa A
    Ann Oncol; 2019 Aug; 30(8):1232-1243. PubMed ID: 31056702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide Real-World Data of Microsatellite Instability and/or Mismatch Repair Deficiency in Cancer: Prevalence and Testing Patterns.
    Fountzilas E; Papadopoulos T; Papadopoulou E; Gouedard C; Kourea HP; Constantoulakis P; Magkou C; Sfakianaki M; Kotoula V; Bantouna D; Raptou G; Saetta AA; Christopoulou G; Hatzibougias D; Michalopoulou-Manoloutsiou E; Siatra E; Eleftheriadis E; Kavoura E; Kaklamanis L; Sourla A; Papaxoinis G; Pavlakis K; Hytiroglou P; Vourlakou C; Arapantoni-Dadioti P; Murray S; Nasioulas G; Timologos G; Fountzilas G; Saridaki Z
    Diagnostics (Basel); 2024 May; 14(11):. PubMed ID: 38893603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mismatch repair-based stratification for immune checkpoint blockade therapy.
    Zhang L; Peng Y; Peng G
    Am J Cancer Res; 2018; 8(10):1977-1988. PubMed ID: 30416850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying mismatch repair-deficient colon cancer: near-perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population-based series.
    Loughrey MB; McGrath J; Coleman HG; Bankhead P; Maxwell P; McGready C; Bingham V; Humphries MP; Craig SG; McQuaid S; Salto-Tellez M; James JA
    Histopathology; 2021 Feb; 78(3):401-413. PubMed ID: 32791559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
    Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A
    Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer.
    Wang C; Kuang W; Zeng J; Ren Y; Liu Q; Sun H; Feng M; Liang D
    PeerJ; 2023; 11():e15920. PubMed ID: 37663290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of mismatch-repair/microsatellite instability-discordant endometrial cancers.
    Riedinger CJ; Esnakula A; Haight PJ; Suarez AA; Chen W; Gillespie J; Villacres A; Chassen A; Cohn DE; Goodfellow PJ; Cosgrove CM
    Cancer; 2024 Feb; 130(3):385-399. PubMed ID: 37751191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancers.
    Liu YL; Weigelt B
    Cancer; 2024 May; 130(10):1733-1746. PubMed ID: 38422006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers.
    Gologan A; Sepulveda AR
    Clin Lab Med; 2005 Mar; 25(1):179-96. PubMed ID: 15749237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability and mismatch repair protein deficiency: equal predictive markers?
    Nádorvári ML; Lotz G; Kulka J; Kiss A; Tímár J
    Pathol Oncol Res; 2024; 30():1611719. PubMed ID: 38655493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Concordance Between Deficient Mismatch Repair and Microsatellite Instability Testing and Their Association with Clinicopathological Features in Colorectal Cancer.
    Bai H; Wang R; Cheng W; Shen Y; Li H; Xia W; Ding Z; Zhang Y
    Cancer Manag Res; 2020; 12():2863-2873. PubMed ID: 32425600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 Patients.
    Ren XY; Song Y; Wang J; Chen LY; Pang JY; Zhou LR; Shen SJ; Cao X; Wang YX; Shao MM; Liang ZY; Sun Q; Wu HW
    Front Oncol; 2021; 11():570623. PubMed ID: 33747906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating mismatch repair deficiency for solid tumor immunotherapy eligibility: immunohistochemistry versus microsatellite molecular testing.
    Saeed OAM; Mann SA; Luchini C; Huang K; Zhang S; Sen JD; Piredda ML; Wang M; Baldrige LA; Sperling RM; Curless KL; Cheng L
    Hum Pathol; 2021 Sep; 115():10-18. PubMed ID: 34052294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical guidance for mismatch repair-deficiency testing in endometrial cancer.
    Stelloo E; Jansen AML; Osse EM; Nout RA; Creutzberg CL; Ruano D; Church DN; Morreau H; Smit VTHBM; van Wezel T; Bosse T
    Ann Oncol; 2017 Jan; 28(1):96-102. PubMed ID: 27742654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status.
    Cohen R; Hain E; Buhard O; Guilloux A; Bardier A; Kaci R; Bertheau P; Renaud F; Bibeau F; Fléjou JF; André T; Svrcek M; Duval A
    JAMA Oncol; 2019 Apr; 5(4):551-555. PubMed ID: 30452494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genes.
    Hájková N; Bártů MK; Cibula D; Drozenová J; Fabian P; Fadare O; Frühauf F; Hausnerová J; Hojný J; Krkavcová E; Laco J; Lax SF; Matěj R; Méhes G; Michálková R; Němejcová K; Singh N; Stolnicu S; Švajdler M; Zima T; McCluggage WG; Stružinská I; Dundr P
    Transl Res; 2023 Oct; 260():61-68. PubMed ID: 37244485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.